X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (152) 152
index medicus (138) 138
heart failure (130) 130
cardiac & cardiovascular systems (127) 127
female (117) 117
male (115) 115
aged (103) 103
mortality (101) 101
cardiovascular (95) 95
middle aged (93) 93
abridged index medicus (56) 56
heart failure - drug therapy (53) 53
internal medicine (52) 52
risk factors (50) 50
heart attacks (49) 49
prognosis (45) 45
drug therapy (43) 43
double-blind method (42) 42
heart failure - mortality (38) 38
cardiology and cardiovascular medicine (35) 35
diabetes (35) 35
cardiac patients (34) 34
morbidity (33) 33
heart failure - physiopathology (32) 32
treatment outcome (32) 32
cardiovascular disease (30) 30
outcomes (30) 30
clinical trials (28) 28
cardiac and cardiovascular systems (27) 27
kardiologi (27) 27
follow-up studies (26) 26
hospitalization (26) 26
trial (25) 25
analysis (24) 24
care and treatment (24) 24
left-ventricular dysfunction (24) 24
proportional hazards models (24) 24
risk (23) 23
survival (23) 23
valsartan (23) 23
tetrazoles - therapeutic use (22) 22
heart attack (21) 21
medicine, general & internal (21) 21
aged, 80 and over (20) 20
heart failure - complications (20) 20
adult (19) 19
angiotensin-converting enzyme inhibitors - therapeutic use (19) 19
cardiology (19) 19
patients (19) 19
prospective studies (19) 19
randomized controlled trials as topic (19) 19
angiotensin ii type 1 receptor blockers - therapeutic use (18) 18
heart (18) 18
heart failure - epidemiology (18) 18
hospitalization - statistics & numerical data (18) 18
stroke (18) 18
patient outcomes (17) 17
time factors (17) 17
association (16) 16
myocardial infarction - complications (16) 16
myocardial-infarction (16) 16
angiotensin (15) 15
cardiovascular diseases (15) 15
chronic kidney-disease (15) 15
epidemiology (15) 15
heart failure - therapy (15) 15
risk assessment (15) 15
studies (15) 15
atrial fibrillation (14) 14
clinical medicine (14) 14
diabetes mellitus, type 2 - complications (14) 14
disease (14) 14
hypertension (14) 14
medical colleges (14) 14
retrospective studies (14) 14
valine - analogs & derivatives (14) 14
acute coronary syndromes (13) 13
acute myocardial-infarction (13) 13
biomarkers - blood (13) 13
confidence intervals (13) 13
dysfunction (13) 13
management (13) 13
myocardial infarction (13) 13
stroke volume (13) 13
captopril (12) 12
chronic disease (12) 12
converting-enzyme-inhibitors (12) 12
diagnosis (12) 12
ejection fraction (12) 12
enalapril (12) 12
heart failure - etiology (12) 12
heart-failure (12) 12
incidence (12) 12
blood pressure (11) 11
candesartan (11) 11
cause of death - trends (11) 11
diabetes mellitus, type 2 - drug therapy (11) 11
enzymes (11) 11
heart failure - blood (11) 11
heart failure - diagnosis (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 14, pp. 1569 - 1569
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 16, pp. 1749 - 1749
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2014, Volume 63, Issue 5, pp. 447 - 456
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 159, Issue 3, pp. 331 - 339
Atrial fibrillation (AF) is associated with increased risk of stroke that can be attenuated with vitamin K antagonists (VKAs). Vitamin K antagonist use is... 
Cardiovascular | XIMELAGATRAN | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTICOAGULATION CONTROL | WARFARIN | ANTITHROMBOTIC THERAPY | PREVENTION | RISK | HEPARIN | ASPIRIN | FACTOR XA INHIBITOR | ANTIPLATELET THERAPY | Pyrazoles - therapeutic use | Factor Xa Inhibitors | Follow-Up Studies | Humans | Middle Aged | Warfarin - adverse effects | Warfarin - therapeutic use | Young Adult | Fibrinolytic Agents - adverse effects | Thromboembolism - prevention & control | Fibrinolytic Agents - therapeutic use | Adult | Pyrazoles - adverse effects | Stroke - prevention & control | Atrial Fibrillation - drug therapy | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Adolescent | Aged | Pyridones - therapeutic use | Hemorrhage - chemically induced | Research Design | Pyridones - adverse effects | Stroke (Disease) | Clinical trials | Medical colleges | Warfarin | Atrial fibrillation | Risk factors | Health care | Anticoagulants | Cardiac arrhythmia | Stroke | Mortality | Thrombosis | Joint replacement surgery | Disease prevention | Blood platelets | Biomarkers | Blood pressure | Diabetes | Drug therapy | Drug dosages | Pyrazoles | Pyridones | Factor Xa | Fibrinolytic Agents | Hemorrhage | Life Sciences | Thromboembolism | Atrial Fibrillation | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 22, pp. 2425 - 2436
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 1, pp. 52 - 61
Objectives The aim of this study was to evaluate the prognostic value of high-sensitivity troponin T (hs-TnT) in addition to clinical risk factors and the CHA2... 
Cardiovascular | Internal Medicine | high-sensitivity troponin T | atrial fibrillation | risk stratification | stroke risk | cardiac troponin | PREDICTING STROKE | MORTALITY | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | ASSAY | VALIDATION | IMPACT | ASSOCIATION | Risk Assessment - methods | United States - epidemiology | Pyrazoles - therapeutic use | Prognosis | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Warfarin - administration & dosage | Incidence | Warfarin - therapeutic use | Pyridones - administration & dosage | Troponin T - blood | Female | Stroke - epidemiology | Stroke - prevention & control | Survival Rate - trends | Double-Blind Method | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Electrocardiography - drug effects | Biomarkers - blood | Atrial Fibrillation - blood | Pyrazoles - administration & dosage | Stroke - etiology | Aged | Pyridones - therapeutic use | Heart failure | Hypertension | Medical colleges | Atrial fibrillation | Emergency medicine | Anticoagulants (Medicine) | Drug therapy | Risk factors | Stroke | Heart attacks | Mortality | Older people | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 3, pp. 241 - 248
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 19, pp. 2059 - 2071
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 55, Issue 15, pp. 1646 - 1646
Journal Article
American Heart Journal, ISSN 0002-8703, 2009, Volume 158, Issue 6, pp. 896 - 901.e3
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 169, Issue 5, pp. 631 - 638.e7
Journal Article